The Health Resources and Services Administration (HRSA) awarded a multiple-award indefinite delivery, indefinite quantity (IDIQ) contract to facilitate the production of focused, high-priority evaluation activities in support of HRSA's bureaus and offices. The IDIQ contract, known as the HRSA Evaluation Studies 2019, has a ceiling value of $50 million and a period of performance through September 2024.
Under this IDIQ, HRSA awarded a $2.8 million firm fixed price delivery order to ICF Macro Inc., a subsidiary of ICF International, Inc. The purpose of this delivery order is to provide evaluation activities, including studies, syntheses, assessments, and measurement tool development, to inform HRSA's programs aimed at improving access to healthcare services. The work is to be performed in Rockville, Maryland over a four-year period. This contract leverages the HRSA Evaluation Studies IDIQ and does not utilize any set-aside designations.
Generated 7/31/24, 9:06 AM